Your browser doesn't support javascript.
loading
Relevance of DNA repair gene polymorphisms to gastric cancer risk and phenotype.
Carrera-Lasfuentes, Patricia; Lanas, Angel; Bujanda, Luis; Strunk, Mark; Quintero, Enrique; Santolaria, Santos; Benito, Rafael; Sopeña, Federico; Piazuelo, Elena; Thomson, Concha; Pérez-Aisa, Angeles; Nicolás-Pérez, David; Hijona, Elizabeth; Espinel, Jesús; Campo, Rafael; Manzano, Marisa; Geijo, Fernando; Pellise, María; Zaballa, Manuel; González-Huix, Ferrán; Espinós, Jorge; Titó, Llúcia; Barranco, Luis; D'Amato, Mauro; García-González, María Asunción.
Afiliação
  • Carrera-Lasfuentes P; CIBER de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain.
  • Lanas A; CIBER de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain.
  • Bujanda L; Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain.
  • Strunk M; Department of Gastroenterology, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
  • Quintero E; Faculty of Medicine, Universidad de Zaragoza, Zaragoza, Spain.
  • Santolaria S; CIBER de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain.
  • Benito R; Department of Gastroenterology, Hospital Donostia/Instituto Biodonostia, Universidad del País Vasco (UPV/EHU), San Sebastián, Spain.
  • Sopeña F; CIBER de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain.
  • Piazuelo E; Instituto Aragonés de Ciencias de la Salud (IACS), Zaragoza, Spain.
  • Thomson C; Department of Gastroenterology, Hospital Universitario de Canarias, Instituto Universitario de Tecnologías Biomédicas (ITB), Centro de Investigación Biomédica de Canarias (CIBICAN), Tenerife, Spain.
  • Pérez-Aisa A; Department of Gastroenterology, Hospital San Jorge, Huesca, Spain.
  • Nicolás-Pérez D; CIBER de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain.
  • Hijona E; Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain.
  • Espinel J; Faculty of Medicine and Department of Microbiology, Hospital Clínico Universitario, Zaragoza, Spain.
  • Campo R; CIBER de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain.
  • Manzano M; Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain.
  • Geijo F; Department of Gastroenterology, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
  • Pellise M; CIBER de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain.
  • Zaballa M; Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain.
  • González-Huix F; Instituto Aragonés de Ciencias de la Salud (IACS), Zaragoza, Spain.
  • Espinós J; Department of Gastroenterology, Hospital Obispo Polanco, Teruel, Spain.
  • Titó L; Department of Gastroenterology, Hospital del Sol, Marbella, Spain.
  • Barranco L; Department of Gastroenterology, Hospital Universitario de Canarias, Instituto Universitario de Tecnologías Biomédicas (ITB), Centro de Investigación Biomédica de Canarias (CIBICAN), Tenerife, Spain.
  • D'Amato M; CIBER de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain.
  • García-González MA; Department of Gastroenterology, Hospital Donostia/Instituto Biodonostia, Universidad del País Vasco (UPV/EHU), San Sebastián, Spain.
Oncotarget ; 8(22): 35848-35862, 2017 May 30.
Article em En | MEDLINE | ID: mdl-28415781
ABSTRACT
Variations in DNA repair genes have been reported as key factors in gastric cancer (GC) susceptibility but results among studies are inconsistent. We aimed to assess the relevance of DNA repair gene polymorphisms and environmental factors to GC risk and phenotype in a Caucasian population in Spain. Genomic DNA from 603 patients with primary GC and 603 healthy controls was typed for 123 single nucleotide polymorphisms in DNA repair genes using the Illumina platform. Helicobacter pylori infection with CagA strains (odds ratio (OR) 1.99; 95% confidence interval (CI) 1.55-2.54), tobacco smoking (OR 1.77; 95% CI 1.22-2.57), and family history of GC (OR 2.87; 95% CI 1.85-4.45) were identified as independent risk factors for GC. By contrast, the TP53 rs9894946A (OR 0.73; 95% CI 0.56-0.96), TP53 rs1042522C (OR 0.76; 95% CI 0.56-0.96), and BRIP1 rs4986764T (OR 0.55; 95% CI 0.38-0.78) variants were associated with lower GC risk. Significant associations with specific anatomopathological GC subtypes were also observed, most notably in the ERCC4 gene with the rs1799801C, rs2238463G, and rs3136038T variants being inversely associated with cardia GC risk. Moreover, the XRCC3 rs861528 allele A was significantly increased in the patient subgroup with diffuse GC (OR 1.75; 95% CI 1.30-2.37). Our data show that specific TP53, BRIP1, ERCC4, and XRCC3 polymorphisms are relevant in susceptibility to GC risk and specific subtypes in Caucasians.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polimorfismo Genético / Neoplasias Gástricas / Predisposição Genética para Doença / Reparo do DNA / Estudos de Associação Genética Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polimorfismo Genético / Neoplasias Gástricas / Predisposição Genética para Doença / Reparo do DNA / Estudos de Associação Genética Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha